Aptose Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.80
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.12
|
-0.11
|
0.01
|
8.33%
|
|
2022-06-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2022-03-31
|
-0.15
|
-0.12
|
0.03
|
20.00%
|
|
2021-12-31
|
-0.17
|
-0.27
|
-0.10
|
-58.82%
|
|
2021-09-30
|
-0.17
|
-0.13
|
0.04
|
23.53%
|
|
2021-06-30
|
-0.19
|
-0.15
|
0.04
|
21.05%
|
|
2021-03-31
|
-0.17
|
-0.18
|
-0.01
|
-5.88%
|
|
2020-12-31
|
-0.17
|
-0.16
|
0.01
|
5.88%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.34
|
|
2021-12-31
|
-0.73
|
|
2020-12-31
|
-0.67
|
|
2019-12-31
|
-0.52
|
|
2018-12-31
|
-0.83
|
|
2017-12-31
|
-0.54
|
|
2016-12-31
|
-1.41
|
|
2015-12-31
|
-1.23
|
|
2014-12-31
|
-1.27
|
|
2013-12-31
|
-1.80
|
|
2012-12-31
|
-1.99
|
|
2011-12-31
|
-3.68
|
|
2010-12-31
|
-6.47
|
|
2009-12-31
|
5.30
|
|
2008-12-31
|
-47.71
|
|
2005-12-31
|
-35.53
|
|
2004-12-31
|
-45.25
|
|
2003-12-31
|
-31.91
|
|
2002-12-31
|
-24.94
|